Back to Journals » OncoTargets and Therapy » Volume 16

LOXL1-AS1 Drives the Progression of Gastric Cancer via Regulating miR-142-5p/PIK3CA Axis [Retraction]

Authors Li M, Cai O, Tan S

Received 23 June 2023

Accepted for publication 23 June 2023

Published 26 June 2023 Volume 2023:16 Pages 473—474

DOI https://doi.org/10.2147/OTT.S427284



Li M, Cai O, Tan S. Onco Targets Ther. 2019;12:11345–11357.

At the authors request, the Editor and Publisher of Onco Targets and Therapy are retracting the published article. Concerns were raised regarding the duplication of cell invasion and migration images. Specifically,

  • The image for Figure 2D, Invasion, BGC823, sh-LOXL1-AS1, has been duplicated with the image for Figure 4D, Invasion, AGS, miR-142-5p.
  • The image for Figure 2D, Invasion, BGC823, sh-NC, has been duplicated with the image for Figure 4D, Invasion, AGS, Control.
  • Figure 2D, Invasion, AGS, Vector, has been duplicated with the image for Figure 4D, Migration, AGS, LOXL1-AS1+miR-142-5p.
  • In addition, the western blot bands in Figure 5C, AGS, PIK3CA and BGC823, PIK3CA appear to have been duplicated.

The authors could not provide a satisfactory explanation for the duplicated images and could only provide partial data for their study. As the findings could not be adequately verified the authors requested to retract the article and the Editor and Publisher agreed with this decision.

We have been informed in our decision-making by our editorial policies and the COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


This retraction relates to this paper


Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.